Jin Medical International Ltd. (ZJYL)
Last Price$0.710.1%
Market Cap$113.4M
ZJYL Rating
ZJYL Quality rating performance
ZJYL Intrinsic Value
Key Highlights:
As of Mar 24, 2025 ZJYL Relative Value is $0.7, which is overvalued by 1.2%, compared to current share price of $0.7.
As of Mar 24, 2025 ZJYL DCF Value is N/A, which is undervalued by N/A, compared to current share price of $0.7.
ZJYL Share Price History
1W (18.5%)
1M (0.8%)
6M (73.8%)
YTD (94.3%)
1Y (74.6%)
3Y 82.2%
5Y 82.2%
10Y 82.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
ZJYL Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$113.4M
$98.3M
$23.5M
($1,352.3K)
Shares Outstanding
157M
Employees
269
Growth (CAGR)
2.9%
(3.7%)
20.53%
(0.7%)
Profitability
40.9%
15.5%
15.6%
(5.1%)
(5.8%)
(36.8%)
Intrinsic Value
$0.7 (1.3% overvalued)
N/A
$0.7
N/A
Return on Capital
Financial Health
($15.2M)
11.2x
40.6%
Dividends
Earnings
Mar 26, 2025
undefined by N/A
undefined by N/A
undefined Beat & undefined Miss
ZJYL Stock Financials
ZJYL Income Statement Metrics
Annual
Quarterly
LTM
ZJYL Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($1,207.3K) N/A YoY
Capital Expenditure (CAPEX)
($1,124.2K) -15.2% YoY
Free Cash Flow (FCF)
($2,331.5K) N/A YoY
ZJYL Income Statement Overview
Annual
Quarterly
LTM
Sep'18
Sep'19
Sep'20
Sep'21
Sep'22
Sep'23
Sep'24
$23.5M 18.6% YoY
Cost of revenue
$14.0M 7.4% YoY
Pre-tax income
$4,183.7K 29.9% YoY
17.8% margin
ZJYL Balance Sheet Overview
Annual
Quarterly
LTM
Sep'18
Sep'19
Sep'20
Sep'21
Sep'22
Sep'23
Sep'24
Assets
Liabilities
Total assets
$45.8M
Current assets ($42.8M, 93.5% of total)
$26.8M (58.4%)
$8,775.7K (19.2%)
Other current assets
$7,283.1K (15.9%)
Non-current assets ($2,984.6K, 6.5% of total)
$0.0 (0.0%)
$1,716.4K (3.7%)
$1,146.8K (2.5%)
Other non-current assets
$121.3K (0.3%)
Financial position
($15.2M)
Cash & Short-term
Investments
Total Debt
ZJYL Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
ZJYL Earnings Surprises
Crunching data... Almost there!
ZJYL Dividends
ZJYL Dividend Yield
Crunching data... Almost there!
ZJYL Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with ZJYL
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$113.4M | 5.5 | $0.7 1.3% overvalued | (74.6%) | $23.5M | ($1,352.3K) | (21.0%) | (5.8%) | 40.9% | 20.8% | 40.6% | |
$181.3B | 7.0 | $109.4 78.5% overvalued | 29.8% | $8,352.1M | $1,303.8M | 17.2% | 15.6% | 67.5% | 26.8% | 0.0% | |
$66.4B | 5.4 | $266.2 16.1% undervalued | (3.5%) | $20.6B | $2,936.0M | 5.9% | 14.2% | 45.2% | 4.9% | 74.4% | |
$45.7B | 6.5 | $58.5 36.7% overvalued | 11.7% | $9,926.1M | $608.0M | 3.6% | 6.1% | 55.6% | 9.1% | 23.8% | |
$32.7B | 7.8 | $193.8 13.1% overvalued | 16.4% | $4,926.8M | $1,388.4M | 12.9% | 28.2% | 57.9% | 23.2% | 16.0% | |
$17.1B | 4.8 | $60.9 81.3% undervalued | (17.4%) | $12.9B | $566.0M | (14.0%) | 4.4% | 37.1% | (1.5%) | 191.5% | |
$16.9B | 6.1 | $141.6 38.9% overvalued | (40.1%) | $2,893.1M | $276.4M | (1.9%) | 9.6% | 34.6% | 18.6% | 11.3% | |
$16.9B | 5.6 | $97.5 15.9% undervalued | (16.7%) | $3,928.5M | $283.5M | 7.2% | 7.2% | 64.4% | 6.1% | 31.3% | |
$14.3B | 7.2 | $128.1 107.0% undervalued | (18.2%) | $4,038.9M | $1,135.5M | 1.8% | 28.1% | 56.2% | 13.4% | 1.6% | |
$9,843.0M | 6.3 | $170.3 15.1% undervalued | 4.7% | $3,582.9M | $349.2M | 2.7% | 9.7% | 34.2% | 12.5% | 27.7% | |
$8,983.9M | 5.2 | $74.9 55.3% overvalued | 20.2% | $2,094.4M | $145.3M | 2.3% | 6.9% | 48.0% | (14.8%) | 69.2% |
FAQ
What is Jin Medical International Ltd. (ZJYL) stock rating?
As of today, Jin Medical International Ltd. has a stock rating of N/A (out of 10), which is considered Great.
is Jin Medical International Ltd. (ZJYL) a good stock to buy?
As of today, Jin Medical International Ltd. has a Great stock rating, which is N/A undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 12.8%.